Proposed Data Collections Submitted for Public Comment and Recommendations, 42096-42097 [E7-14886]
Download as PDF
<![CDATA[
42096
Federal Register / Vol. 72, No. 147 / Wednesday, August 1, 2007 / Notices
jlentini on PROD1PC65 with NOTICES
transport passengers and cargo on U.S.
Government procured transportation for
both scheduled and charter flights,
subject to certain conditions.
Specifically, community airlines may
transport passengers and cargo on
scheduled and charter flights for which
a U.S. Government civilian department,
agency, or instrumentality:
(1) Obtains the transportation for itself
or in carrying out an arrangement under
which payment is made by the U.S.
Government or payment is made from
amounts provided for the use of the U.S.
Government, or
(2) Provides the transportation to or
for a foreign country or international or
other organization without
reimbursement, and the transportation
is:
(a) between any point in the United
States and any point in a Member State,
except—with respect to passengers
only—between points for which there is
a city-pair contract fare in effect, or
(b) between any two points outside
the United States.
This provision described above does
not apply to transportation funded by
the Secretary of Defense or the Secretary
of a military department.
The Federal Travel Regulation (FTR),
section 301–10.135 (b) (41 CFR 301–
10.135(b)) includes an exception to the
use of U.S. flag air carrier service when
the transportation is provided under a
bilateral or multilateral air
transportation agreement to which the
U.S. Government and the government of
a foreign country are parties, and which
the Department of Transportation has
determined meets the requirements of
the Fly America Act. As the U.S.–EU
Open Skies agreement is such an air
transportation agreement, the General
Services Administration (GSA) intends
to issue regulations addressing the
content of the provision on U.S.
Government procured transportation
included in the agreement to ensure that
all are aware of the change made by the
agreement. Regulations addressing air
passenger transportation will be
included in the FTR.
GSA is in the process of drafting a
proposed rule with request for
comments on proposed revisions to the
FTR that will be published in the
Federal Register.
Dated: July 17, 2007.
Becky Rhodes,
Deputy Associate Administrator.
[FR Doc. E7–14900 Filed 7–31–07; 8:45 am]
BILLING CODE 6820–14–P
VerDate Aug<31>2005
20:12 Jul 31, 2007
Jkt 211001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day-07–0026]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Report of Verified Case of
Tuberculosis (RVCT), (OMB No. 0920–
0026)—Revision—National Center for
HIV/AIDS, Viral Hepatitis, STD, and TB
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
In the United States, an estimated 10
to 15 million people are infected with
Mycobacterium tuberculosis and about
10% of these persons will develop
tuberculosis (TB) disease at some point
in their lives. The purpose of this
project is to conduct the first major
revision since 1993 of the national
tuberculosis surveillance form, the
Report of Verified Case of Tuberculosis
(RVCT), to capture changes in the
diagnosis and treatment of TB, and to
better monitor trends in TB
PO 00000
Frm 00055
Fmt 4703
Sfmt 4703
epidemiology and outbreaks, in order to
develop strategies to meet the national
goal of TB elimination.
CDC currently conducts and
maintains the national surveillance
system pursuant to the provisions of
section 301(a) of the Public Service Act
[42 U.S.C. 241] and section 306 of the
Public Service Act [42 U.S.C. 241(a)].
Data are collected by 60 reporting areas
(the 50 states, the District of Columbia,
New York City, Puerto Rico, and 7
jurisdictions in the Pacific and
Caribbean). In 2001, CDC’s Division of
Tuberculosis Elimination (DTBE)
initiated a comprehensive review of the
RVCT. A work group with nearly 30
members from 15 TB programs, CDC,
and the National TB Controllers
Association (NTCA) convened 26
conference calls to consider variable
revisions based on surveillance
significance, ease of data collection, and
ability to yield meaningful and useful
data. The proposed revision further
benefited from review by TB experts
active in research and field services and
was pilot-tested in two phases.
Revisions resulting from stakeholder
input include the capture of data on
verified TB cases who do not meet the
national surveillance definition since
counted by another U.S. area, TB
treatment was initiated in another
country, or TB recurred less than 12
months after completion of therapy. The
year the case was reported and the
reporting jurisdiction were incorporated
into state case identification number
with fields for linking state case
numbers to allow better tracking of such
cases. New variables reflecting
diagnostic updates since 1993 include
nucleic acid amplification, interferon
gamma release assay, computerized
tomography, and genotyping. The dates
of tuberculin skin test and of specimen
collection for other diagnostic tests,
along with result dates by laboratory
type, were added. The primary reason
the patient was evaluated for TB
disease, and reasons for extending TB
therapy beyond one year were added.
Risk characteristics such as diabetes,
end-stage renal disease, post-organ
transplantation, other
immunosuppression, anti-tumor
necrosis factor-alpha therapy, contact
with a drug-resistant case, contact with
an infectious case, missed contacts,
incomplete treatment for latent TB
infection, immigration status for TB
screening, and parental origin and
international background for pediatric
cases will also be collected. A variable
was added to capture whether the TB
patient moved during treatment and if
so, where, with a check box to indicate
E:\FR\FM\01AUN1.SGM
01AUN1
Federal Register / Vol. 72, No. 147 / Wednesday, August 1, 2007 / Notices
transnational referral. Modifications
include updates to drug regimens and
drug susceptibility tests. Date of death
and whether TB was a cause of death
were added to status at diagnosis. Major
site and additional sites of TB disease
were combined to a single question.
Smear, pathology, or cytology now
capture histology results in addition to
microbiology, and a single field for
anatomic specimen code replaced two
codes for positive specimens. Initial
chest radiograph or other chest imaging
was updated to capture whether an
abnormal chest image shows a cavity or
miliary TB, replacing miliary as a site of
disease and simplifying check boxes for
radiograph as cavitary, consistent with
TB, stable, worsening, improving, or
unknown. Whether patients were under
custody of Immigration and Customs
Enforcement was added to the
correctional facility variable, and
occupation was modified to capture the
past year, with check boxes to
differentiate persons not eligible for
employment from the unemployed.
Type of health care provider was
clarified with categories of outpatient
care. Reasons for culture conversion not
being documented were incorporated,
and adverse treatment event and death
were added as reasons TB therapy
stopped or never started. Deletions
include removal of: (1) Soundex, a
software code; (2) a text field to indicate
who submitted the RVCT; (3) a check
box asking whether the case was
anergic; (4) CDC AIDS patient number;
(5) how HIV positive status was
determined; (6) a check box for more
than one additional site of TB disease;
and (7) site of directly observed therapy.
DTBE is currently working with
stakeholders and software team
members towards development and
implementation of an updated software
module for the transition from the
current software for RVCT data entry
and electronic transmission of reports to
CDC to collection and reporting of
revised RVCT data. Following the
transition, respondents will be able to
use either the CDC associated TB
module or their own TB surveillance
application to collect and report RVCT
42097
data to CDC. CDC publishes an annual
report using RVCT data to summarize
national TB statistics and also
periodically conducts special analyses
for publication to further describe and
interpret national TB data. These data
assist in public health planning,
evaluation, and resource allocation.
Reporting areas also review and analyze
their RVCT data to monitor local TB
trends, evaluate program success, and
focus resources to eliminate TB. No
other Federal agency collects this type
of national TB data. In addition to
providing technical assistance on the
use of RVCT, CDC provides technical
support for reporting software. In this
request, CDC is requesting approval for
approximately 8050 burden hours, an
estimated increase of 490 hours. This
increase is due to the addition of
information on new clinical diagnostic
tests and factors to identify high-risk
patients. There is no cost to respondents
other than their time to participate in
the survey.
ESTIMATE OF ANNUALIZED BURDEN HOURS
Types of respondents
Number of
respondents
No. of
responses per
respondent
Average burden per
response
(in hours)
Total burden
(in hours)
Local, state, and territorial health departments ...............................................
60
230
35/60
8050
Dated: July 26, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for
Disease Control and Prevention.
[FR Doc. E7–14886 Filed 7–31–07; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60 Day–07–07BI]
jlentini on PROD1PC65 with NOTICES
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call 404–639–5960 and
VerDate Aug<31>2005
20:12 Jul 31, 2007
Jkt 211001
send comments to Maryam I. Daneshvar,
CDC Acting Reports Clearance Officer,
1600 Clifton Road, MS–D74, Atlanta,
GA 30333 or send an e-mail to
omb@cdc.gov.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. Written comments should
be received within 60 days of this
notice.
Proposed Project
Rapid HIV Testing in Community
Mental Health Settings Serving African
Americans—New—National Center for
HIV, Viral Hepatitis, STD and TB
PO 00000
Frm 00056
Fmt 4703
Sfmt 4703
Prevention (NCHHSTP), Centers for
Disease Control and Prevention (CDC).
Background and Brief Description
People with chronic mental illness,
including those with substance use
disorders, are at increased risk of HIV
infection compared with the general
population. However, not enough is
known about the risk behaviors,
willingness to be tested for HIV, and
HIV prevalence among persons with
chronic mental illness. In addition, the
interrelations among diagnosis of HIV
infection, compliance with medical
care, subsequent risk behaviors, and the
course of mental illness have not been
well-described. Mental health clinics
are an important setting for HIV rapid
testing and promoting prevention efforts
against the transmission of HIV
infection.
The objectives of this project are to (1)
increase the number of mental health
providers who routinely provide HIV
counseling, testing, and linkage to care
in settings that provide mental health
care, especially those serving African
American communities; and (2) describe
the relationship between mental illness,
E:\FR\FM\01AUN1.SGM
01AUN1
]]>Agencies
[Federal Register Volume 72, Number 147 (Wednesday, August 1, 2007)]
[Notices]
[Pages 42096-42097]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-14886]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-07-0026]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call 404-639-5960
and send comments to Maryam I. Daneshvar, CDC Acting Reports Clearance
Officer, 1600 Clifton Road, MS-D74, Atlanta, GA 30333 or send an e-mail
to omb@cdc.gov.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. Written comments should be received
within 60 days of this notice.
Proposed Project
Report of Verified Case of Tuberculosis (RVCT), (OMB No. 0920-
0026)--Revision--National Center for HIV/AIDS, Viral Hepatitis, STD,
and TB Prevention (NCHHSTP), Centers for Disease Control and Prevention
(CDC).
Background and Brief Description
In the United States, an estimated 10 to 15 million people are
infected with Mycobacterium tuberculosis and about 10% of these persons
will develop tuberculosis (TB) disease at some point in their lives.
The purpose of this project is to conduct the first major revision
since 1993 of the national tuberculosis surveillance form, the Report
of Verified Case of Tuberculosis (RVCT), to capture changes in the
diagnosis and treatment of TB, and to better monitor trends in TB
epidemiology and outbreaks, in order to develop strategies to meet the
national goal of TB elimination.
CDC currently conducts and maintains the national surveillance
system pursuant to the provisions of section 301(a) of the Public
Service Act [42 U.S.C. 241] and section 306 of the Public Service Act
[42 U.S.C. 241(a)]. Data are collected by 60 reporting areas (the 50
states, the District of Columbia, New York City, Puerto Rico, and 7
jurisdictions in the Pacific and Caribbean). In 2001, CDC's Division of
Tuberculosis Elimination (DTBE) initiated a comprehensive review of the
RVCT. A work group with nearly 30 members from 15 TB programs, CDC, and
the National TB Controllers Association (NTCA) convened 26 conference
calls to consider variable revisions based on surveillance
significance, ease of data collection, and ability to yield meaningful
and useful data. The proposed revision further benefited from review by
TB experts active in research and field services and was pilot-tested
in two phases. Revisions resulting from stakeholder input include the
capture of data on verified TB cases who do not meet the national
surveillance definition since counted by another U.S. area, TB
treatment was initiated in another country, or TB recurred less than 12
months after completion of therapy. The year the case was reported and
the reporting jurisdiction were incorporated into state case
identification number with fields for linking state case numbers to
allow better tracking of such cases. New variables reflecting
diagnostic updates since 1993 include nucleic acid amplification,
interferon gamma release assay, computerized tomography, and
genotyping. The dates of tuberculin skin test and of specimen
collection for other diagnostic tests, along with result dates by
laboratory type, were added. The primary reason the patient was
evaluated for TB disease, and reasons for extending TB therapy beyond
one year were added. Risk characteristics such as diabetes, end-stage
renal disease, post-organ transplantation, other immunosuppression,
anti-tumor necrosis factor-alpha therapy, contact with a drug-resistant
case, contact with an infectious case, missed contacts, incomplete
treatment for latent TB infection, immigration status for TB screening,
and parental origin and international background for pediatric cases
will also be collected. A variable was added to capture whether the TB
patient moved during treatment and if so, where, with a check box to
indicate
[[Page 42097]]
transnational referral. Modifications include updates to drug regimens
and drug susceptibility tests. Date of death and whether TB was a cause
of death were added to status at diagnosis. Major site and additional
sites of TB disease were combined to a single question. Smear,
pathology, or cytology now capture histology results in addition to
microbiology, and a single field for anatomic specimen code replaced
two codes for positive specimens. Initial chest radiograph or other
chest imaging was updated to capture whether an abnormal chest image
shows a cavity or miliary TB, replacing miliary as a site of disease
and simplifying check boxes for radiograph as cavitary, consistent with
TB, stable, worsening, improving, or unknown. Whether patients were
under custody of Immigration and Customs Enforcement was added to the
correctional facility variable, and occupation was modified to capture
the past year, with check boxes to differentiate persons not eligible
for employment from the unemployed. Type of health care provider was
clarified with categories of outpatient care. Reasons for culture
conversion not being documented were incorporated, and adverse
treatment event and death were added as reasons TB therapy stopped or
never started. Deletions include removal of: (1) Soundex, a software
code; (2) a text field to indicate who submitted the RVCT; (3) a check
box asking whether the case was anergic; (4) CDC AIDS patient number;
(5) how HIV positive status was determined; (6) a check box for more
than one additional site of TB disease; and (7) site of directly
observed therapy. DTBE is currently working with stakeholders and
software team members towards development and implementation of an
updated software module for the transition from the current software
for RVCT data entry and electronic transmission of reports to CDC to
collection and reporting of revised RVCT data. Following the
transition, respondents will be able to use either the CDC associated
TB module or their own TB surveillance application to collect and
report RVCT data to CDC. CDC publishes an annual report using RVCT data
to summarize national TB statistics and also periodically conducts
special analyses for publication to further describe and interpret
national TB data. These data assist in public health planning,
evaluation, and resource allocation. Reporting areas also review and
analyze their RVCT data to monitor local TB trends, evaluate program
success, and focus resources to eliminate TB. No other Federal agency
collects this type of national TB data. In addition to providing
technical assistance on the use of RVCT, CDC provides technical support
for reporting software. In this request, CDC is requesting approval for
approximately 8050 burden hours, an estimated increase of 490 hours.
This increase is due to the addition of information on new clinical
diagnostic tests and factors to identify high-risk patients. There is
no cost to respondents other than their time to participate in the
survey.
Estimate of Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
No. of Average burden
Types of respondents Number of responses per per response Total burden
respondents respondent (in hours) (in hours)
----------------------------------------------------------------------------------------------------------------
Local, state, and territorial health 60 230 35/60 8050
departments................................
----------------------------------------------------------------------------------------------------------------
Dated: July 26, 2007.
Maryam I. Daneshvar,
Acting Reports Clearance Officer, Centers for Disease Control and
Prevention.
[FR Doc. E7-14886 Filed 7-31-07; 8:45 am]
BILLING CODE 4163-18-P
